{
    "abstract": "The development of a chlamydial vaccine that elicits protective mucosal immunity is of paramount importance in combatting the global spread of sexually transmitted Chlamydia trachomatis (Ct) infections. While the identification and prioritization of chlamydial antigens is a crucial prerequisite for efficacious vaccine design, it is likely that novel adjuvant development and selection will also play a pivotal role in the translational potential of preclinical Ct vaccines. Although the molecular nature of the immuno-modulatory component is of primary importance, adjuvant formulation and delivery systems may also govern vaccine efficacy and potency. Our study provides the first preclinical evaluation of recombinant Ct polymorphic membrane protein D (rPmpD) in combination with three different formulations of a novel second-generation lipid adjuvant (SLA). SLA was rationally designed in silico by modification of glucopyranosyl lipid adjuvant (GLA), a TLR4 agonistic precursor molecule currently in Phase II clinical development. We demonstrate robust protection against intra-vaginal Ct challenge in mice, evidenced by significantly enhanced resistance to infection and reduction in mean bacterial load. Strikingly, protection was found to correlate with the presence of robust anti-rPmpD serum and cervico-vaginal IgG titres, even in the absence of adjuvant-induced Th1-type cellular immune responses elicited by each SLA formulation, and we further show that anti-rPmpD antibodies recognize Ct EBs. These findings highlight the utility of SLA and rational molecular design of adjuvants in preclinical Ct vaccine development, but also suggest an important role for anti-rPmpD antibodies in protection against urogenital Ct infection.",
    "author_highlights": [
        {
            "endOffset": 13326,
            "sentence": "rPmpD in combination with SLA elicits significant protection against intra-vaginal Ct challenge.",
            "startOffset": 13230
        },
        {
            "endOffset": 13404,
            "sentence": "Antibodies induced by immunisation with rPmpD recognise Ct elementary bodies.",
            "startOffset": 13327
        },
        {
            "endOffset": 13504,
            "sentence": "SLA is a novel adjuvant class that may be widely used in future preclinical Ct vaccine development.",
            "startOffset": 13405
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Lori",
                    "initial": "L.",
                    "last": "Newman"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Rowley"
                },
                {
                    "first": "Stephen Vander",
                    "initial": "S.V.",
                    "last": "Hoorn"
                },
                {
                    "first": "Nalinka Saman",
                    "initial": "N.S.",
                    "last": "Wijesooriya"
                },
                {
                    "first": "Magnus",
                    "initial": "M.",
                    "last": "Unemo"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Low"
                },
                {
                    "first": "Gretchen",
                    "initial": "G.",
                    "last": "Stevens"
                },
                {
                    "first": "Sami",
                    "initial": "S.",
                    "last": "Gottlieb"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Kiarie"
                },
                {
                    "first": "Marleen",
                    "initial": "M.",
                    "last": "Temmerman"
                }
            ],
            "doi": "10.1371/journal.pone.0143304",
            "issn": "19326203",
            "pmid": "26646541",
            "pub_year": 2015,
            "title": "Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting",
            "volume": "10"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Jeffrey F.",
                    "initial": "J.F.",
                    "last": "Peipert"
                }
            ],
            "doi": "10.1056/NEJMcp030542",
            "firstpage": "2424",
            "issn": "00284793",
            "lastpage": "2430",
            "pmid": "14681509",
            "pub_year": 2003,
            "title": "Genital Chlamydial Infections",
            "volume": "349"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Brunham"
                },
                {
                    "first": "Michael L.",
                    "initial": "M.L.",
                    "last": "Rekart"
                }
            ],
            "doi": "10.1097/OLQ.0b013e31815e41a3",
            "firstpage": "53",
            "issn": "01485717",
            "lastpage": "54",
            "pmid": "18157065",
            "pub_year": 2008,
            "title": "The arrested immunity hypothesis and the epidemiology of chlamydia control",
            "volume": "35"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Brunham"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.01.024",
            "firstpage": "1892",
            "issn": "0264410X",
            "lastpage": "1897",
            "pmid": "23375977",
            "pub_year": 2013,
            "title": "Chlamydia trachomatis control requires a vaccine",
            "volume": "31"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Evelien",
                    "initial": "E.",
                    "last": "De Clercq"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Kalmar"
                },
                {
                    "first": "Daisy",
                    "initial": "D.",
                    "last": "Vanrompay"
                }
            ],
            "doi": "10.1128/IAI.00357-13",
            "firstpage": "3060",
            "issn": "00199567",
            "lastpage": "3067",
            "pub_year": 2013,
            "title": "Animal models for studying female genital tract infection with chlamydia trachomatis",
            "volume": "81"
        },
        "b0030": {
            "authors": [
                {
                    "first": "L. M.",
                    "initial": "L.M.",
                    "last": "De la Maza"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Pal"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Khamesipour"
                },
                {
                    "first": "E. M.",
                    "initial": "E.M.",
                    "last": "Peterson"
                }
            ],
            "firstpage": "2094",
            "issn": "00199567",
            "lastpage": "2097",
            "pmid": "8168974",
            "pub_year": 1994,
            "title": "Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility",
            "volume": "62"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Joseph M.",
                    "initial": "J.M.",
                    "last": "Lyons"
                },
                {
                    "first": "Servaas A.",
                    "initial": "S.A.",
                    "last": "Morr\u00e9"
                },
                {
                    "first": "Lucy P.",
                    "initial": "L.P.",
                    "last": "Airo-Brown"
                },
                {
                    "first": "Amado S.",
                    "initial": "A.S.",
                    "last": "Pe\u00f1a"
                },
                {
                    "first": "James I.",
                    "initial": "J.I.",
                    "last": "Ito"
                }
            ],
            "firstpage": "383",
            "issn": "16841182",
            "lastpage": "393",
            "pmid": "16341338",
            "pub_year": 2005,
            "title": "Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice",
            "volume": "38"
        },
        "b0040": {
            "authors": [
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Lyons"
                },
                {
                    "first": "J. I.",
                    "initial": "J.I.",
                    "last": "Ito"
                },
                {
                    "first": "A. S.",
                    "initial": "A.S.",
                    "last": "Pe\u00f1a"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "Morr\u00e9"
                }
            ],
            "doi": "10.1136/jcp.2004.021543",
            "firstpage": "397",
            "issn": "00219746",
            "lastpage": "401",
            "pmid": "15790704",
            "pub_year": 2005,
            "title": "Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum",
            "volume": "58"
        },
        "b0045": {
            "authors": [
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Nelson"
                },
                {
                    "first": "Dezso P.",
                    "initial": "D.P.",
                    "last": "Virok"
                },
                {
                    "first": "Heidi",
                    "initial": "H.",
                    "last": "Wood"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Roshick"
                },
                {
                    "first": "Raymond M.",
                    "initial": "R.M.",
                    "last": "Johnson"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Whitmire"
                },
                {
                    "first": "Deborah D.",
                    "initial": "D.D.",
                    "last": "Crane"
                },
                {
                    "first": "Olivia",
                    "initial": "O.",
                    "last": "Steele-Mortimer"
                },
                {
                    "first": "Laszlo",
                    "initial": "L.",
                    "last": "Kari"
                },
                {
                    "first": "Grant",
                    "initial": "G.",
                    "last": "McClarty"
                },
                {
                    "first": "Harlan D.",
                    "initial": "H.D.",
                    "last": "Caldwell"
                }
            ],
            "doi": "10.1073/pnas.0504198102",
            "firstpage": "10658",
            "issn": "00278424",
            "lastpage": "10663",
            "pmid": "16020528",
            "pub_year": 2005,
            "title": "Chlamydial IFN-\u03b3 immune evasion is linked to host infection tropism",
            "volume": "102"
        },
        "b0050": {
            "authors": [
                {
                    "first": "T. D.",
                    "initial": "T.D.",
                    "last": "Read"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "Brunham"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Shen"
                },
                {
                    "first": "S. R.",
                    "initial": "S.R.",
                    "last": "Gill"
                },
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Heidelberg"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "White"
                },
                {
                    "first": "E. K.",
                    "initial": "E.K.",
                    "last": "Hickey"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Peterson"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Utterback"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Berry"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Bass"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Linher"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Weidman"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Khouri"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Craven"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Bowman"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Dodson"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Gwinn"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Nelson"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "DeBoy"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Kolonay"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "McClarty"
                },
                {
                    "first": "S. L.",
                    "initial": "S.L.",
                    "last": "Salzberg"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Eisen"
                },
                {
                    "first": "C. M.",
                    "initial": "C.M.",
                    "last": "Fraser"
                }
            ],
            "doi": "10.1093/nar/28.6.1397",
            "firstpage": "1397",
            "issn": "03051048",
            "lastpage": "1406",
            "pmid": "10684935",
            "pub_year": 2000,
            "title": "Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39",
            "volume": "28"
        },
        "b0055": {
            "authors": [
                {
                    "first": "John H.",
                    "initial": "J.H.",
                    "last": "Carlson"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Hughes"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Hogan"
                },
                {
                    "first": "Gordon",
                    "initial": "G.",
                    "last": "Cieplak"
                },
                {
                    "first": "Daniel E.",
                    "initial": "D.E.",
                    "last": "Sturdevant"
                },
                {
                    "first": "Grant",
                    "initial": "G.",
                    "last": "McClarty"
                },
                {
                    "first": "Harlan D.",
                    "initial": "H.D.",
                    "last": "Caldwell"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Belland"
                }
            ],
            "doi": "10.1128/IAI.72.12.7063-7072.2004",
            "firstpage": "7063",
            "issn": "00199567",
            "lastpage": "7072",
            "pmid": "15557630",
            "pub_year": 2004,
            "title": "Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates",
            "volume": "72"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Illya",
                    "initial": "I.",
                    "last": "Tietzel"
                },
                {
                    "first": "Christelle",
                    "initial": "C.",
                    "last": "El-Haibi"
                },
                {
                    "first": "Rey A.",
                    "initial": "R.A.",
                    "last": "Carabeo"
                }
            ],
            "doi": "10.1371/journal.pone.0006499",
            "issn": "19326203",
            "pmid": "19652711",
            "pub_year": 2009,
            "title": "Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-\u03b3",
            "volume": "4"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Belland"
                },
                {
                    "first": "Marci A.",
                    "initial": "M.A.",
                    "last": "Scidmore"
                },
                {
                    "first": "Deborah D.",
                    "initial": "D.D.",
                    "last": "Crane"
                },
                {
                    "first": "Daniel M.",
                    "initial": "D.M.",
                    "last": "Hogan"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Whitmire"
                },
                {
                    "first": "Grant",
                    "initial": "G.",
                    "last": "McClarty"
                },
                {
                    "first": "Harlan D.",
                    "initial": "H.D.",
                    "last": "Caldwell"
                }
            ],
            "doi": "10.1073/pnas.241377698",
            "firstpage": "13984",
            "issn": "00278424",
            "lastpage": "13989",
            "pmid": "11707582",
            "pub_year": 2001,
            "title": "Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes",
            "volume": "98"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Gail L.",
                    "initial": "G.L.",
                    "last": "Sturdevant"
                },
                {
                    "first": "Harlan D.",
                    "initial": "H.D.",
                    "last": "Caldwell"
                }
            ],
            "doi": "10.1111/2049-632X.12164",
            "firstpage": "70",
            "issn": "2049632X",
            "lastpage": "73",
            "pmid": "24585717",
            "pub_year": 2014,
            "title": "Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract",
            "volume": "72"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Rhea N.",
                    "initial": "R.N.",
                    "last": "Coler"
                },
                {
                    "first": "Ajay",
                    "initial": "A.",
                    "last": "Bhatia"
                },
                {
                    "first": "Jean Francois",
                    "initial": "J.F.",
                    "last": "Maisonneuve"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Probst"
                },
                {
                    "first": "Brenda",
                    "initial": "B.",
                    "last": "Barth"
                },
                {
                    "first": "Pamela",
                    "initial": "P.",
                    "last": "Ovendale"
                },
                {
                    "first": "Hang",
                    "initial": "H.",
                    "last": "Fang"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Alderson"
                },
                {
                    "first": "Yves",
                    "initial": "Y.",
                    "last": "Lobet"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen"
                },
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "Mettens"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1111/j.1574-695X.2008.00527.x",
            "firstpage": "258",
            "issn": "09288244",
            "lastpage": "270",
            "pmid": "19281568",
            "pub_year": 2009,
            "title": "Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis",
            "volume": "55"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Francis O.",
                    "initial": "F.O.",
                    "last": "Eko"
                },
                {
                    "first": "Qing",
                    "initial": "Q.",
                    "last": "He"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Brown"
                },
                {
                    "first": "Lucinda",
                    "initial": "L.",
                    "last": "McMillan"
                },
                {
                    "first": "Godwin O.",
                    "initial": "G.O.",
                    "last": "Ifere"
                },
                {
                    "first": "Godwin A.",
                    "initial": "G.A.",
                    "last": "Ananaba"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Lyn"
                },
                {
                    "first": "Werner",
                    "initial": "W.",
                    "last": "Lubitz"
                },
                {
                    "first": "Kathryn L.",
                    "initial": "K.L.",
                    "last": "Kellar"
                },
                {
                    "first": "Carolyn M.",
                    "initial": "C.M.",
                    "last": "Black"
                },
                {
                    "first": "Joseph U.",
                    "initial": "J.U.",
                    "last": "Igietseme"
                }
            ],
            "doi": "10.4049/jimmunol.173.5.3375",
            "firstpage": "3375",
            "issn": "00221767",
            "lastpage": "3382",
            "pmid": "15322201",
            "pub_year": 2004,
            "title": "A novel recombinant multisubunit vaccine against Chlamydia",
            "volume": "173"
        },
        "b0085": {
            "authors": [
                {
                    "first": "F. O.",
                    "initial": "F.O.",
                    "last": "Eko"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Ekong"
                },
                {
                    "first": "Q.",
                    "initial": "Q.",
                    "last": "He"
                },
                {
                    "first": "C. M.",
                    "initial": "C.M.",
                    "last": "Black"
                },
                {
                    "first": "J. U.",
                    "initial": "J.U.",
                    "last": "Igietseme"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.12.024",
            "firstpage": "1472",
            "issn": "0264410X",
            "lastpage": "1480",
            "pmid": "21184858",
            "pub_year": 2011,
            "title": "Induction of immune memory by a multisubunit chlamydial vaccine",
            "volume": "29"
        },
        "b0090": {
            "authors": [
                {
                    "first": "L. H.",
                    "initial": "L.H.",
                    "last": "Collier"
                },
                {
                    "first": "W. A.",
                    "initial": "W.A.",
                    "last": "Blyth"
                },
                {
                    "first": "N. M.",
                    "initial": "N.M.",
                    "last": "Larin"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Treharne"
                }
            ],
            "doi": "10.1017/S0022172400045575",
            "firstpage": "97",
            "issn": "00221724",
            "lastpage": "107",
            "pub_year": 1967,
            "title": "Immunogenicity of experimental trachoma vaccines in baboons: III. Experiments with inactivated vaccines",
            "volume": "65"
        },
        "b0095": {
            "authors": [
                {
                    "first": "San Pin",
                    "initial": "S.P.",
                    "last": "Wang"
                },
                {
                    "first": "J. Thomas",
                    "initial": "J.T.",
                    "last": "Grayston"
                },
                {
                    "first": "E. Russell",
                    "initial": "E.R.",
                    "last": "Alexander"
                }
            ],
            "firstpage": "1615",
            "issn": "00029394",
            "lastpage": "1630",
            "pmid": "4960884",
            "pub_year": 1967,
            "title": "Trachoma vaccine studies in monkeys",
            "volume": "63"
        },
        "b0100": {
            "authors": [
                {
                    "first": "David C.W.",
                    "initial": "D.C.W.",
                    "last": "Mabey"
                },
                {
                    "first": "Victor",
                    "initial": "V.",
                    "last": "Hu"
                },
                {
                    "first": "Robin L.",
                    "initial": "R.L.",
                    "last": "Bailey"
                },
                {
                    "first": "Matthew J.",
                    "initial": "M.J.",
                    "last": "Burton"
                },
                {
                    "first": "Martin J.",
                    "initial": "M.J.",
                    "last": "Holland"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.10.016",
            "firstpage": "1572",
            "issn": "0264410X",
            "lastpage": "1578",
            "pmid": "24606636",
            "pub_year": 2014,
            "title": "Towards a safe and effective chlamydial vaccine: Lessons from the eye",
            "volume": "32"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Yu"
                },
                {
                    "first": "Karuna P.",
                    "initial": "K.P.",
                    "last": "Karunakaran"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Kelly"
                },
                {
                    "first": "Caixia",
                    "initial": "C.",
                    "last": "Shen"
                },
                {
                    "first": "Xiaozhou",
                    "initial": "X.",
                    "last": "Jiang"
                },
                {
                    "first": "Leonard J.",
                    "initial": "L.J.",
                    "last": "Foster"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Brunham"
                }
            ],
            "doi": "10.4049/jimmunol.1002952",
            "firstpage": "3615",
            "issn": "00221767",
            "lastpage": "3621",
            "pmid": "21296978",
            "pub_year": 2011,
            "title": "Immunization with live and dead chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: Correlation with MHC class II peptide presentation and multifunctional Th1 cells",
            "volume": "186"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Yu"
                },
                {
                    "first": "Karuna P.",
                    "initial": "K.P.",
                    "last": "Karunakaran"
                },
                {
                    "first": "Xiaozhou",
                    "initial": "X.",
                    "last": "Jiang"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Brunham"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.06.002",
            "firstpage": "4672",
            "issn": "0264410X",
            "lastpage": "4680",
            "pmid": "24992718",
            "pub_year": 2014,
            "title": "Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice",
            "volume": "32"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Nunes"
                },
                {
                    "first": "Jo\u00e3o P.",
                    "initial": "J.P.",
                    "last": "Gomes"
                },
                {
                    "first": "Karuna P.",
                    "initial": "K.P.",
                    "last": "Karunakaran"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Brunham"
                }
            ],
            "doi": "10.1371/journal.pone.0131695",
            "issn": "19326203",
            "pmid": "26131720",
            "pub_year": 2015,
            "title": "Bioinformatic analysis of Chlamydia trachomatis polymorphic membrane proteins PmpE, PmpF, PmpG and PmpH as potential vaccine antigens",
            "volume": "10"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Kena A.",
                    "initial": "K.A.",
                    "last": "Swanson"
                },
                {
                    "first": "Lacey D.",
                    "initial": "L.D.",
                    "last": "Taylor"
                },
                {
                    "first": "Shaun D.",
                    "initial": "S.D.",
                    "last": "Frank"
                },
                {
                    "first": "Gail L.",
                    "initial": "G.L.",
                    "last": "Sturdevant"
                },
                {
                    "first": "Elizabeth R.",
                    "initial": "E.R.",
                    "last": "Fischer"
                },
                {
                    "first": "John H.",
                    "initial": "J.H.",
                    "last": "Carlson"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Whitmire"
                },
                {
                    "first": "Harlan D.",
                    "initial": "H.D.",
                    "last": "Caldwell"
                }
            ],
            "doi": "10.1128/IAI.01173-08",
            "firstpage": "508",
            "issn": "00199567",
            "lastpage": "516",
            "pmid": "19001072",
            "pub_year": 2009,
            "title": "Chlamydia trachomatis polymorphic membrane protein D is an oligomeric autotransporter with a higher-order structure",
            "volume": "77"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Laszlo",
                    "initial": "L.",
                    "last": "Kari"
                },
                {
                    "first": "Timothy R.",
                    "initial": "T.R.",
                    "last": "Southern"
                },
                {
                    "first": "Carey J.",
                    "initial": "C.J.",
                    "last": "Downey"
                },
                {
                    "first": "Heather S.",
                    "initial": "H.S.",
                    "last": "Watkins"
                },
                {
                    "first": "Linnell B.",
                    "initial": "L.B.",
                    "last": "Randall"
                },
                {
                    "first": "Lacey D.",
                    "initial": "L.D.",
                    "last": "Taylor"
                },
                {
                    "first": "Gail L.",
                    "initial": "G.L.",
                    "last": "Sturdevant"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Whitmire"
                },
                {
                    "first": "Harlan D.",
                    "initial": "H.D.",
                    "last": "Caldwell"
                }
            ],
            "doi": "10.1128/IAI.01686-14",
            "firstpage": "2756",
            "issn": "00199567",
            "lastpage": "2762",
            "pmid": "24733093",
            "pub_year": 2014,
            "title": "Chlamydia trachomatis polymorphic membrane protein D is a virulence factor involved in early host-cell interactions",
            "volume": "82"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Elisabeth",
                    "initial": "E.",
                    "last": "Becker"
                },
                {
                    "first": "Johannes H.",
                    "initial": "J.H.",
                    "last": "Hegemann"
                }
            ],
            "doi": "10.1002/mbo3.186",
            "firstpage": "544",
            "issn": "20458827",
            "lastpage": "556",
            "pmid": "24985494",
            "pub_year": 2014,
            "title": "All subtypes of the Pmp adhesin family are implicated in chlamydial virulence and show species-specific function",
            "volume": "3"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Rhea N.",
                    "initial": "R.N.",
                    "last": "Coler"
                },
                {
                    "first": "Sylvie",
                    "initial": "S.",
                    "last": "Bertholet"
                },
                {
                    "first": "Magdalini",
                    "initial": "M.",
                    "last": "Moutaftsi"
                },
                {
                    "first": "Jeff A.",
                    "initial": "J.A.",
                    "last": "Guderian"
                },
                {
                    "first": "Hillarie Plessner",
                    "initial": "H.P.",
                    "last": "Windish"
                },
                {
                    "first": "Susan L.",
                    "initial": "S.L.",
                    "last": "Baldwin"
                },
                {
                    "first": "Elsa M.",
                    "initial": "E.M.",
                    "last": "Laughlin"
                },
                {
                    "first": "Malcolm S.",
                    "initial": "M.S.",
                    "last": "Duthie"
                },
                {
                    "first": "Christopher B.",
                    "initial": "C.B.",
                    "last": "Fox"
                },
                {
                    "first": "Darrick",
                    "initial": "D.",
                    "last": "Carter"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Friede"
                },
                {
                    "first": "Thomas S.",
                    "initial": "T.S.",
                    "last": "Vedvick"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1371/journal.pone.0016333",
            "issn": "19326203",
            "pmid": "21298114",
            "pub_year": 2011,
            "title": "Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant",
            "volume": "6"
        },
        "b0140": {
            "authors": [
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Treanor"
                },
                {
                    "first": "Brandon",
                    "initial": "B.",
                    "last": "Essink"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Hull"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Reed"
                },
                {
                    "first": "Ruvim",
                    "initial": "R.",
                    "last": "Izikson"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Patriarca"
                },
                {
                    "first": "Karen L.",
                    "initial": "K.L.",
                    "last": "Goldenthal"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Kohberger"
                },
                {
                    "first": "Lisa M.",
                    "initial": "L.M.",
                    "last": "Dunkle"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.08.064",
            "firstpage": "5760",
            "issn": "0264410X",
            "lastpage": "5765",
            "pmid": "24075920",
            "pub_year": 2013,
            "title": "Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant",
            "volume": "31"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Yibing",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Simona",
                    "initial": "S.",
                    "last": "Kahane"
                },
                {
                    "first": "Lesley T.",
                    "initial": "L.T.",
                    "last": "Cutcliffe"
                },
                {
                    "first": "Rachel J.",
                    "initial": "R.J.",
                    "last": "Skilton"
                },
                {
                    "first": "Paul R.",
                    "initial": "P.R.",
                    "last": "Lambden"
                },
                {
                    "first": "Kenneth",
                    "initial": "K.",
                    "last": "Persson"
                },
                {
                    "first": "Carina",
                    "initial": "C.",
                    "last": "Bjartling"
                },
                {
                    "first": "Ian N.",
                    "initial": "I.N.",
                    "last": "Clarke"
                }
            ],
            "doi": "10.1371/journal.pone.0059195",
            "issn": "19326203",
            "pmid": "23527131",
            "pub_year": 2013,
            "title": "Genetic Transformation of a Clinical (Genital Tract), Plasmid-Free Isolate of Chlamydia trachomatis: Engineering the Plasmid as a Cloning Vector",
            "volume": "8"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Andrey O.",
                    "initial": "A.O.",
                    "last": "Kiselev"
                },
                {
                    "first": "Megan C.",
                    "initial": "M.C.",
                    "last": "Skinner"
                },
                {
                    "first": "Mary F.",
                    "initial": "M.F.",
                    "last": "Lampe"
                }
            ],
            "doi": "10.1371/journal.pone.0005191",
            "issn": "19326203",
            "pmid": "19367336",
            "pub_year": 2009,
            "title": "Analysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis Serovars A, D, and L2",
            "volume": "4"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Shigui",
                    "initial": "S.",
                    "last": "Liu"
                },
                {
                    "first": "Rowel",
                    "initial": "R.",
                    "last": "Tobias"
                },
                {
                    "first": "Shannon",
                    "initial": "S.",
                    "last": "McClure"
                },
                {
                    "first": "Garth",
                    "initial": "G.",
                    "last": "Styba"
                },
                {
                    "first": "Qinwei",
                    "initial": "Q.",
                    "last": "Shi"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Jackowski"
                }
            ],
            "doi": "10.1016/S0009-9120(97)00049-0",
            "firstpage": "455",
            "issn": "00099120",
            "lastpage": "463",
            "pmid": "9316739",
            "pub_year": 1997,
            "title": "Removal of endotoxin from recombinant protein preparations",
            "volume": "30"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Anthony L.",
                    "initial": "A.L.",
                    "last": "Desbien"
                },
                {
                    "first": "Steven J.",
                    "initial": "S.J.",
                    "last": "Reed"
                },
                {
                    "first": "Hilton R.",
                    "initial": "H.R.",
                    "last": "Bailor"
                },
                {
                    "first": "Natasha Dubois",
                    "initial": "N.D.",
                    "last": "Cauwelaert"
                },
                {
                    "first": "John D.",
                    "initial": "J.D.",
                    "last": "Laurance"
                },
                {
                    "first": "Mark T.",
                    "initial": "M.T.",
                    "last": "Orr"
                },
                {
                    "first": "Christopher B.",
                    "initial": "C.B.",
                    "last": "Fox"
                },
                {
                    "first": "Darrick",
                    "initial": "D.",
                    "last": "Carter"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                },
                {
                    "first": "Malcolm S.",
                    "initial": "M.S.",
                    "last": "Duthie"
                }
            ],
            "doi": "10.1002/eji.201444543",
            "firstpage": "407",
            "issn": "00142980",
            "lastpage": "417",
            "pmid": "25367751",
            "pub_year": 2015,
            "title": "Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-\u03b3",
            "volume": "45"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Niels Peter H.",
                    "initial": "N.P.H.",
                    "last": "Knudsen"
                },
                {
                    "first": "Anja",
                    "initial": "A.",
                    "last": "Olsen"
                },
                {
                    "first": "Cecilia",
                    "initial": "C.",
                    "last": "Buonsanti"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Follmann"
                },
                {
                    "first": "Yuan",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Rhea N.",
                    "initial": "R.N.",
                    "last": "Coler"
                },
                {
                    "first": "Christopher B.",
                    "initial": "C.B.",
                    "last": "Fox"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Meinke"
                },
                {
                    "first": "Ugo",
                    "initial": "U.",
                    "last": "D\u00f3ro"
                },
                {
                    "first": "Daniele",
                    "initial": "D.",
                    "last": "Casini"
                },
                {
                    "first": "Alessandra",
                    "initial": "A.",
                    "last": "Bonci"
                },
                {
                    "first": "Rolf",
                    "initial": "R.",
                    "last": "Billeskov"
                },
                {
                    "first": "Ennio",
                    "initial": "E.",
                    "last": "De Gregorio"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Ali M.",
                    "initial": "A.M.",
                    "last": "Harandi"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Andersen"
                },
                {
                    "first": "Else Marie",
                    "initial": "E.M.",
                    "last": "Agger"
                }
            ],
            "doi": "10.1038/srep19570",
            "issn": "20452322",
            "pmid": "26791076",
            "pub_year": 2016,
            "title": "Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens",
            "volume": "6"
        },
        "b0170": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Su"
                },
                {
                    "first": "H. D.",
                    "initial": "H.D.",
                    "last": "Caldwell"
                }
            ],
            "firstpage": "3302",
            "issn": "00199567",
            "lastpage": "3308",
            "pmid": "7642259",
            "pub_year": 1995,
            "title": "CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract",
            "volume": "63"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Georg",
                    "initial": "G.",
                    "last": "Stary"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Olive"
                },
                {
                    "first": "Aleksandar F.",
                    "initial": "A.F.",
                    "last": "Radovic-Moreno"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Gondek"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Alvarez"
                },
                {
                    "first": "Pamela A.",
                    "initial": "P.A.",
                    "last": "Basto"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Perro"
                },
                {
                    "first": "Vladimir D.",
                    "initial": "V.D.",
                    "last": "Vrbanac"
                },
                {
                    "first": "Andrew M.",
                    "initial": "A.M.",
                    "last": "Tager"
                },
                {
                    "first": "Jinjun",
                    "initial": "J.",
                    "last": "Shi"
                },
                {
                    "first": "Jeremy A.",
                    "initial": "J.A.",
                    "last": "Yethon"
                },
                {
                    "first": "Omid C.",
                    "initial": "O.C.",
                    "last": "Farokhzad"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Langer"
                },
                {
                    "first": "Michael N.",
                    "initial": "M.N.",
                    "last": "Starnbach"
                },
                {
                    "first": "Ulrich H.",
                    "initial": "U.H.",
                    "last": "Von Andrian"
                }
            ],
            "doi": "10.1126/science.aaa8205",
            "issn": "00368075",
            "pmid": "26089520",
            "pub_year": 2015,
            "title": "A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells",
            "volume": "348"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Sandra G.",
                    "initial": "S.G.",
                    "last": "Morrison"
                },
                {
                    "first": "Richard P.",
                    "initial": "R.P.",
                    "last": "Morrison"
                }
            ],
            "doi": "10.4049/jimmunol.175.11.7536",
            "firstpage": "7536",
            "issn": "00221767",
            "lastpage": "7542",
            "pmid": "16301662",
            "pub_year": 2005,
            "title": "A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection",
            "volume": "175"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Anja W.",
                    "initial": "A.W.",
                    "last": "Olsen"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Follmann"
                },
                {
                    "first": "Karin",
                    "initial": "K.",
                    "last": "Erneholm"
                },
                {
                    "first": "Ida",
                    "initial": "I.",
                    "last": "Rosenkrands"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Andersen"
                }
            ],
            "doi": "10.1093/infdis/jiv137",
            "firstpage": "978",
            "issn": "00221899",
            "lastpage": "989",
            "pmid": "25748320",
            "pub_year": 2015,
            "title": "Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein",
            "volume": "212"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Simona",
                    "initial": "S.",
                    "last": "St\u00e4ger"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Alexander"
                },
                {
                    "first": "Alun C.",
                    "initial": "A.C.",
                    "last": "Kirby"
                },
                {
                    "first": "Marina",
                    "initial": "M.",
                    "last": "Botto"
                },
                {
                    "first": "Nico",
                    "initial": "N.",
                    "last": "Van Rooijen"
                },
                {
                    "first": "Deborah F.",
                    "initial": "D.F.",
                    "last": "Smith"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Brombacher"
                },
                {
                    "first": "Paul M.",
                    "initial": "P.M.",
                    "last": "Kaye"
                }
            ],
            "doi": "10.1038/nm933",
            "firstpage": "1287",
            "issn": "10788956",
            "lastpage": "1292",
            "pmid": "14502281",
            "pub_year": 2003,
            "title": "Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses",
            "volume": "9"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Yasir A.W.",
                    "initial": "Y.A.W.",
                    "last": "Skeiky"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Kennedy"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Kaufman"
                },
                {
                    "first": "Monamaris M.",
                    "initial": "M.M.",
                    "last": "Borges"
                },
                {
                    "first": "Jeffrey A.",
                    "initial": "J.A.",
                    "last": "Guderian"
                },
                {
                    "first": "John K.",
                    "initial": "J.K.",
                    "last": "Scholler"
                },
                {
                    "first": "Pamela J.",
                    "initial": "P.J.",
                    "last": "Ovendale"
                },
                {
                    "first": "Kathleen S.",
                    "initial": "K.S.",
                    "last": "Picha"
                },
                {
                    "first": "Philip J.",
                    "initial": "P.J.",
                    "last": "Morrissey"
                },
                {
                    "first": "Kenneth H.",
                    "initial": "K.H.",
                    "last": "Grabstein"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Campos-Neto"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "firstpage": "6171",
            "issn": "00221767",
            "lastpage": "6179",
            "pmid": "9834103",
            "pub_year": 1998,
            "title": "LeIF: A recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile",
            "volume": "161"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Yasir A.W.",
                    "initial": "Y.A.W.",
                    "last": "Skeiky"
                },
                {
                    "first": "Jeffrey A.",
                    "initial": "J.A.",
                    "last": "Guderian"
                },
                {
                    "first": "Darin R.",
                    "initial": "D.R.",
                    "last": "Benson"
                },
                {
                    "first": "Olivia",
                    "initial": "O.",
                    "last": "Bacelar"
                },
                {
                    "first": "Edgar M.",
                    "initial": "E.M.",
                    "last": "Carvalho"
                },
                {
                    "first": "Marek",
                    "initial": "M.",
                    "last": "Kubin"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Badaro"
                },
                {
                    "first": "Giorgio",
                    "initial": "G.",
                    "last": "Trinchieri"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1084/jem.181.4.1527",
            "firstpage": "1527",
            "issn": "00221007",
            "lastpage": "1537",
            "pmid": "7699334",
            "pub_year": 1995,
            "title": "A recombinant leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12",
            "volume": "181"
        },
        "b0205": {
            "authors": [
                {
                    "first": "H. D.",
                    "initial": "H.D.",
                    "last": "Cladwell"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": "Cho Chou Kuo"
                },
                {
                    "first": "G. E.",
                    "initial": "G.E.",
                    "last": "Kenny"
                }
            ],
            "firstpage": "969",
            "issn": "00221767",
            "lastpage": "975",
            "pmid": "51883",
            "pub_year": 1975,
            "title": "Antigenic analysis of chlamydiae by two dimensional immunoelectrophoresis. II. A trachoma LGV specific antigen",
            "volume": "115"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Chun",
                    "initial": "C.",
                    "last": "Tan"
                },
                {
                    "first": "Ru Ching",
                    "initial": "R.C.",
                    "last": "Hsia"
                },
                {
                    "first": "Huizhong",
                    "initial": "H.",
                    "last": "Shou"
                },
                {
                    "first": "Catherine L.",
                    "initial": "C.L.",
                    "last": "Haggerty"
                },
                {
                    "first": "Roberta B.",
                    "initial": "R.B.",
                    "last": "Ness"
                },
                {
                    "first": "Charlotte A.",
                    "initial": "C.A.",
                    "last": "Gaydos"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Dean"
                },
                {
                    "first": "Amy M.",
                    "initial": "A.M.",
                    "last": "Scurlock"
                },
                {
                    "first": "David P.",
                    "initial": "D.P.",
                    "last": "Wilson"
                },
                {
                    "first": "Patrik M.",
                    "initial": "P.M.",
                    "last": "Bavoil"
                }
            ],
            "doi": "10.1128/IAI.01566-08",
            "firstpage": "3218",
            "issn": "00199567",
            "lastpage": "3226",
            "pmid": "19487469",
            "pub_year": 2009,
            "title": "Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family",
            "volume": "77"
        }
    },
    "body_text": [
        {
            "endOffset": 31121,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Mean bacterial load over time was quantified using an integrative area under the curve (AUC) method (Fig. 6B).",
            "startOffset": 31011,
            "title": "Vaccination with rPmpD in the presence or absence of SLA significantly enhances resistance to Ct infection and reduces mean bacterial load"
        },
        {
            "endOffset": 15840,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 15839,
                    "startOffset": 15836
                }
            },
            "secId": "s0005",
            "sentence": "Aggressive \u2018seek and treat\u2019 public health measures have not stemmed the rise of infection rates, leading to proposal of the \u2018arrested immunity\u2019 hypothesis [3].",
            "startOffset": 15681,
            "title": "Introduction"
        },
        {
            "endOffset": 22959,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "6\u20138 week old female C57BL/6 mice were bred and maintained under specific pathogen-free conditions at the University of York, allocated to groups and immunized subcutaneously (s.c.) at the base of the tail on days 0, 21 and 42 with 100 \u03bcl of sterile PBS containing 5 \u03bcg/dose of adjuvant (SLA-AF, SLA-SE or SLA-LSQ) with 5 \u03bcg/dose rPmpD or 2 \u00d7 107 inclusion forming units (IFU) of UVEBs.",
            "startOffset": 22574,
            "title": "Mouse immunizations"
        },
        {
            "endOffset": 16987,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 16986,
                    "startOffset": 16983
                }
            },
            "secId": "s0005",
            "sentence": "Furthermore, it has been suggested that Ct infection in mice may more closely mimic the self-limiting infections in women that rarely progress so quickly to upper-genital tract pathology [8].",
            "startOffset": 16796,
            "title": "Introduction"
        },
        {
            "endOffset": 15942,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 15941,
                    "startOffset": 15938
                }
            },
            "secId": "s0005",
            "sentence": "This suggests vaccination as a key step in controlling and potentially eliminating Ct infections [4].",
            "startOffset": 15841,
            "title": "Introduction"
        },
        {
            "endOffset": 36860,
            "parents": [],
            "secId": "s0085",
            "sentence": "This research was supported by a Wellcome Trust PhD studentship to Wayne Paes (Grant 097325/Z/11/Z) and the Bill and Melinda Gates Foundation (Grants #42387 and OPP1055855) to SGR and DC.",
            "startOffset": 36673,
            "title": "Financial support"
        },
        {
            "endOffset": 24020,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Cervico-vaginal washes were stored at \u221280 \u00b0C until use.",
            "startOffset": 23965,
            "title": "Cervico-vaginal washes"
        },
        {
            "endOffset": 19605,
            "parents": [],
            "secId": "s0005",
            "sentence": "We demonstrate robust protection against urogenital Ct infection in C57BL/6 mice, characterized by significantly enhanced resistance to infection and bacterial clearance.",
            "startOffset": 19435,
            "title": "Introduction"
        },
        {
            "endOffset": 26531,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "For multiple comparisons, groups were compared using a one-way analysis of variance (ANOVA) following transformation of skewed distributions in STATA/IC 10 (StataCorp, USA).",
            "startOffset": 26358,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 22062,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Oil-in-water emulsions (SLA-SE) were manufactured by high-speed mixing poloxamer 188, glycerol, and ammonium phosphate buffer with an oil phase (squalene, dimyristoyl phosphatidylcholine) and SLA.",
            "startOffset": 21866,
            "title": "Second-generation lipid adjuvant formulations"
        },
        {
            "endOffset": 21337,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 21190,
                    "startOffset": 21186
                }
            },
            "secId": "s0020",
            "sentence": "Following 0.1% Triton X-114 extraction of E. coli LPS [31], the Limulus Amebocyte Lysate test was utilised to determine the amount of endotoxin in the rPmpD preparation, which was found to be below 1EU/mg.",
            "startOffset": 21132,
            "title": "Preparation of recombinant PmpD and UV-inactivated Ct EB vaccines"
        },
        {
            "endOffset": 34659,
            "parents": [],
            "secId": "s0080",
            "sentence": "However, mice immunized with rPmpD alone fail to completely resolve infection at day 22 (Fig. 5A), suggesting that adaptive rPmpD-specific cellular immune responses may be important at enhancing bacterial clearance.",
            "startOffset": 34444,
            "title": "Discussion"
        },
        {
            "endOffset": 20495,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 20494,
                    "startOffset": 20490
                }
            },
            "secId": "s0015",
            "sentence": "Ct serovar E/Bour (American Type Culture Collection [ATCC]) and Ct serovar D/UW3/Cx (Prof. Shattock, Imperial College) were propagated in McCoy cells (ATCC) and purified as described previously [29].",
            "startOffset": 20296,
            "title": "Ct cell culture"
        },
        {
            "endOffset": 15482,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 15481,
                    "startOffset": 15478
                }
            },
            "secId": "s0005",
            "sentence": "Chlamydia trachomatis (Ct) is the most common sexually transmitted bacterial pathogen worldwide, responsible for \u223c131 million new cases of disease each year [1].",
            "startOffset": 15321,
            "title": "Introduction"
        },
        {
            "endOffset": 31285,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "All antigen-adjuvant combinations elicited enhanced resistance to infection and significant reduction in bacterial burden relative to sham-immunized mice (Fig. 6).",
            "startOffset": 31122,
            "title": "Vaccination with rPmpD in the presence or absence of SLA significantly enhances resistance to Ct infection and reduces mean bacterial load"
        },
        {
            "endOffset": 36207,
            "parents": [],
            "secId": "s0080",
            "sentence": "A prophylactic chlamydial vaccine that reduces infectious burden or time to clearance is likely to have significant global healthcare benefits.",
            "startOffset": 36064,
            "title": "Discussion"
        },
        {
            "endOffset": 17964,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 17963,
                    "startOffset": 17956
                },
                "b0080": {
                    "endOffset": 17963,
                    "startOffset": 17956
                },
                "b0085": {
                    "endOffset": 17963,
                    "startOffset": 17956
                }
            },
            "secId": "s0005",
            "sentence": "However, the study also indicates a dual role for adaptive immunity in reducing Ct bacterial burden and time to clearance, and vaccine-induced protective immunity has previously been investigated in mice using Ct as the agent of infection [15\u201317].",
            "startOffset": 17717,
            "title": "Introduction"
        },
        {
            "endOffset": 35615,
            "parents": [],
            "secId": "s0080",
            "sentence": "Further work is now required to detail the underpinnings of other likely immuno-modulatory properties of rPmpD.",
            "startOffset": 35504,
            "title": "Discussion"
        },
        {
            "endOffset": 19435,
            "parents": [],
            "refoffsets": {
                "b0135": {
                    "endOffset": 19335,
                    "startOffset": 19331
                },
                "b0140": {
                    "endOffset": 19434,
                    "startOffset": 19430
                }
            },
            "secId": "s0005",
            "sentence": "SLA was designed in silico (Carter et al., submitted) through rational modification of the terminal acyl chains of glucopyranosyl lipid adjuvant (GLA) [27], a precursor molecule that has demonstrated tolerability and immunogenicity in Phase 1 trials [28].",
            "startOffset": 19180,
            "title": "Introduction"
        },
        {
            "endOffset": 35504,
            "parents": [],
            "secId": "s0080",
            "sentence": "Our study demonstrates the efficacy of subcutaneous vaccination at eliciting robust antigen-specific mucosal IgG responses, and we further show that immune serum from rPmpD-immunized mice cross-reacts with UVEBs in ELISA (Fig. 4C), confirming antibody recognition of the agent of infection.",
            "startOffset": 35214,
            "title": "Discussion"
        },
        {
            "endOffset": 16300,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 16299,
                    "startOffset": 16296
                }
            },
            "secId": "s0005",
            "sentence": "Ct or the mouse pneumonitis biovar Chlamydia muridarum (Cm) have been utilised to study chlamydial infections and vaccine efficacy in mice, although neither model mimics all aspects of human disease and pathogenesis [5].",
            "startOffset": 16080,
            "title": "Introduction"
        },
        {
            "endOffset": 27643,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "However, mice immunized with rPmpD in combination with all SLA formulations showed significantly elevated antigen-specific IFN\u03b3 responses relative to all control groups (p \u2a7d 0.05).",
            "startOffset": 27463,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 24187,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Serum was obtained on days 0, 35 and 56 following initial immunization and 6 weeks post challenge.",
            "startOffset": 24089,
            "title": "Measurement of serum and cervico-vaginal antigen-specific antibody"
        },
        {
            "endOffset": 33536,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 33535,
                    "startOffset": 33531
                }
            },
            "secId": "s0080",
            "sentence": "A similar phenomenon has recently been observed where un-adjuvanted recombinant Ct MOMP elicited comparable antibody responses to adjuvanted MOMP, which correlated with protection [33].",
            "startOffset": 33351,
            "title": "Discussion"
        },
        {
            "endOffset": 27732,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Formulation-specific differences in the magnitude of the T cell responses were observed.",
            "startOffset": 27644,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 34862,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 34861,
                    "startOffset": 34857
                }
            },
            "secId": "s0080",
            "sentence": "Very few studies have highlighted a role for Ct-specific antibodies in vaccine-mediated protection, although antibody-mediated protection has previously been described in the Cm model of infection [36].",
            "startOffset": 34660,
            "title": "Discussion"
        },
        {
            "endOffset": 32794,
            "parents": [],
            "secId": "s0080",
            "sentence": "Our study demonstrates the formulation-specific efficacy of SLA, a novel TLR4 agonist, at inducing Th1-biased immune responses and protection against Ct infection in combination with rPmpD in vivo.",
            "startOffset": 32597,
            "title": "Discussion"
        },
        {
            "endOffset": 23873,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "100 \u03bcl of sterile-filtered PBS were pipetted up-and-down the vaginal cavity ten times using a Microman Precision Microliter Pipette with rounded-tip capillary pistons (Gilson).",
            "startOffset": 23697,
            "title": "Cervico-vaginal washes"
        },
        {
            "endOffset": 29064,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "As class switching to IgG2c is mediated by IFN\u03b3, these data are consistent with the cytokine results shown in Fig. 1.",
            "startOffset": 28947,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 34084,
            "parents": [],
            "secId": "s0080",
            "sentence": "Unexpectedly, despite the generation of robust Ct-specific humoral responses, the authors reported no definitive role for antibody-mediated protection, and detect no significant difference in recoverable IFU between immunized and na\u00efve mice at day 1 post challenge.",
            "startOffset": 33819,
            "title": "Discussion"
        },
        {
            "endOffset": 18943,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 18942,
                    "startOffset": 18935
                },
                "b0130": {
                    "endOffset": 18942,
                    "startOffset": 18935
                }
            },
            "secId": "s0005",
            "sentence": "Furthermore, PmpD has been implicated in mediating early host-cell interactions [25,26].",
            "startOffset": 18855,
            "title": "Introduction"
        },
        {
            "endOffset": 17503,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 17502,
                    "startOffset": 17495
                },
                "b0065": {
                    "endOffset": 17502,
                    "startOffset": 17495
                }
            },
            "secId": "s0005",
            "sentence": "The cytotoxin gene is thought to influence chlamydial sensitivity to IFN\u03b3 through targeting of GTPases, and may differentially mediate innate immune evasion in the host [12,13].",
            "startOffset": 17326,
            "title": "Introduction"
        },
        {
            "endOffset": 25756,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Briefly, 96-well MultiScreen filtration plates (Millipore) were coated overnight at 4 \u00b0C with IFN\u03b3, IL-5 or IL-10 monoclonal capture antibodies (Mabtech).",
            "startOffset": 25602,
            "title": "Antigen-specific cellular responses"
        },
        {
            "endOffset": 32586,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "SLA-SE elicited the most robust rPmpD-specific IFN\u03b3 recall responses pre- and post-challenge, and resulted in the shortest time to clearance when coupled with either rPmpD or UVEBs (Fig. 5).",
            "startOffset": 32396,
            "title": "Vaccination with rPmpD in the presence or absence of SLA significantly enhances resistance to Ct infection and reduces mean bacterial load"
        },
        {
            "endOffset": 18473,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 18472,
                    "startOffset": 18465
                },
                "b0110": {
                    "endOffset": 18472,
                    "startOffset": 18465
                }
            },
            "secId": "s0005",
            "sentence": "Recent studies using Cm have highlighted a promising role for chlamydial polymorphic membrane proteins (Pmps) as vaccine candidates [21,22].",
            "startOffset": 18333,
            "title": "Introduction"
        },
        {
            "endOffset": 22573,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "All animal care and experimental procedures were performed under UK Home Office License (Ref # PPL 70/7805) and with approval from the Animal Procedures and Ethics Committee of the University of York.",
            "startOffset": 22373,
            "title": "Mouse immunizations"
        },
        {
            "endOffset": 21770,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Aqueous formulations (SLA-AF) were manufactured by mixing SLA with dipalmitoyl phosphatidylcholine (DPPC) at a DPPC:SLA molar ratio of 2:1 in chloroform, and evaporated.",
            "startOffset": 21601,
            "title": "Second-generation lipid adjuvant formulations"
        },
        {
            "endOffset": 18332,
            "parents": [],
            "secId": "s0005",
            "sentence": "Hence, identification and prioritization of novel chlamydial antigens that elicit protective cell-mediated and/or humoral immunity is of great importance.",
            "startOffset": 18178,
            "title": "Introduction"
        },
        {
            "endOffset": 26852,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "A total of 5 animals were sufficient to detect expected effect sizes with a power of 0\u00b78 (alpha = 0\u00b705) for all experimental readouts.",
            "startOffset": 26718,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 33227,
            "parents": [],
            "refoffsets": {
                "b0160": {
                    "endOffset": 33226,
                    "startOffset": 33222
                }
            },
            "secId": "s0080",
            "sentence": "Early IFN\u03b3 and IL-18 production by neutrophils and memory CD8+ T cells was ablated in caspase-1/11\u2013/\u2013 and IL-18 receptor 1\u2013/\u2013 mice following administration of GLA-SE, thus proposing a mechanistic basis for the observed potency of SLA-SE in our study [32].",
            "startOffset": 32972,
            "title": "Discussion"
        },
        {
            "endOffset": 27462,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In the absence of adjuvant, immunization with rPmpD elicited a minimal recall IFN\u03b3 response, with no detectable significant difference from control groups (Fig. 1A).",
            "startOffset": 27297,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 25849,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Splenocytes (2.5 \u00d7 105 cells/well) were added to the plate in the presence of 1 \u03bcg/ml rPmpD.",
            "startOffset": 25757,
            "title": "Antigen-specific cellular responses"
        },
        {
            "endOffset": 15680,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 15679,
                    "startOffset": 15676
                }
            },
            "secId": "s0005",
            "sentence": "Urogenital infections are asymptomatic in 30\u201350% of men and 70\u201390% of women, with major complications such as pelvic inflammatory disease (PID) and infertility occurring predominantly in women [2].",
            "startOffset": 15483,
            "title": "Introduction"
        },
        {
            "endOffset": 28010,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "SLA-SE elicited the most robust IFN\u03b3 response following stimulation with rPmpD (>500 spots/250,000 spleen cells), with no significant difference between IFN\u03b3 levels in SLA-AF-immunized (76 \u00b1 38 cells/250,000) and SLA-LSQ-immunized mice (145 \u00b1 81/250,000) detected (p = 0.1739).",
            "startOffset": 27733,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 31582,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "No significant differences in resistance to infection or bacterial burden between PBS-immunized mice and adjuvant only groups (SLA-AF, SLA-SE, SLA-LSQ) were observed, suggesting non-specific innate immune activation by SLA formulations in the absence of antigen does not play a role in protection.",
            "startOffset": 31285,
            "title": "Vaccination with rPmpD in the presence or absence of SLA significantly enhances resistance to Ct infection and reduces mean bacterial load"
        },
        {
            "endOffset": 32971,
            "parents": [],
            "secId": "s0080",
            "sentence": "The enhanced magnitude of both innate and adaptive cellular responses observed with squalene emulsions (SE) has previously been associated with inflammasome activation in vivo.",
            "startOffset": 32795,
            "title": "Discussion"
        },
        {
            "endOffset": 29545,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Consistent with serum IgG subclasses, no detectable levels of IgG2c were observed in mice immunized with rPmpD alone.",
            "startOffset": 29428,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 28300,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Although the rPmpD-specific IL-10 response was significantly augmented with the SLA-SE and SLA-AF formulations (Fig. 1E), the significantly enhanced IFN\u03b3:IL-10 ratio elicited by the SLA-SE-rPmpD vaccine clearly indicates that SLA-SE biases towards robust Th1-type immune responses in vivo.",
            "startOffset": 28011,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 37583,
            "parents": [],
            "secId": "s0090",
            "sentence": "SGR is a founder of, and holds an equity interest in, Immune Design, a licensee of certain rights associated with GLA and SLA.",
            "startOffset": 37457,
            "title": "Potential conflicts of interest"
        },
        {
            "endOffset": 22351,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The liposomal formulation (SLA-LSQ) was mixed with aqueous QS21 following addition of dioleoyl phosphatidylcholine:cholesterol (4:1 w/w ratio) with SLA in chloroform and hydration in 25 mM ammonium phosphate buffer (pH \u223c5.7) with sonication to achieve a monodisperse particle size \u223c80 nm.",
            "startOffset": 22063,
            "title": "Second-generation lipid adjuvant formulations"
        },
        {
            "endOffset": 23590,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Cervico-vaginal swabs were obtained on days 1, 3, 7, 14 and 22 post-challenge, and the total number of inclusions per well were enumerated in a blinded fashion using fluorescence microscopy.",
            "startOffset": 23400,
            "title": "Vaginal Ct challenge and determination of chlamydial load"
        },
        {
            "endOffset": 31010,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "For quantification of resistance to infection, recoverable IFU at day 1 were compared between each group using a one-way ANOVA (Fig. 6A).",
            "startOffset": 30873,
            "title": "Vaccination with rPmpD in the presence or absence of SLA significantly enhances resistance to Ct infection and reduces mean bacterial load"
        },
        {
            "endOffset": 20256,
            "parents": [],
            "secId": "s0005",
            "sentence": "Hence, we propose that anti-rPmpD antibodies may play a significant role in vaccine-mediated protection against intra-vaginal Ct challenge, and demonstrate that SLA represents a novel adjuvant class that may be more widely utilised in future chlamydial vaccine development.",
            "startOffset": 19983,
            "title": "Introduction"
        },
        {
            "endOffset": 24541,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Plates were washed four times with 300 \u03bcl/well wash buffer (1\u00d7 PBS, 0.05% Tween-20), and all subsequent washing steps carried out in identical fashion using an automated SkanWasher 400 (Molecular Devices, USA).",
            "startOffset": 24331,
            "title": "Measurement of serum and cervico-vaginal antigen-specific antibody"
        },
        {
            "endOffset": 32158,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Strikingly, rPmpD administered in the absence of SLA resulted in significantly enhanced resistance to infection and reduced bacterial load relative to sham-immunized mice (Fig. 6), although all individuals within this group failed to completely resolve infection (Fig. 5A).",
            "startOffset": 31885,
            "title": "Vaccination with rPmpD in the presence or absence of SLA significantly enhances resistance to Ct infection and reduces mean bacterial load"
        },
        {
            "endOffset": 34443,
            "parents": [],
            "secId": "s0080",
            "sentence": "Although possible vaccine-induced innate effector mechanisms cannot be ruled out, protection in our study correlates with the presence of robust pathogen-specific serum and mucosal antibody titres irrespective of SLA-induced Th1-bias.",
            "startOffset": 34209,
            "title": "Discussion"
        },
        {
            "endOffset": 37426,
            "parents": [],
            "secId": "s0085",
            "sentence": "The content of this publication is solely the responsibility of the authors and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.",
            "startOffset": 37135,
            "title": "Financial support"
        },
        {
            "endOffset": 29293,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "All rPmpD-SLA combinations induced robust IgG1 and IgG2c rPmpD-specific titres, with demonstrable increases in titres following successive immunizations that also remained elevated 6 weeks post infection with Ct (Fig. 2B and D).",
            "startOffset": 29065,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 34209,
            "parents": [],
            "secId": "s0080",
            "sentence": "In contrast, we demonstrate significantly reduced recoverable IFU on day 1 between rPmpD- and sham-immunized mice (Fig. 6A).",
            "startOffset": 34085,
            "title": "Discussion"
        },
        {
            "endOffset": 31884,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Furthermore, the time to complete clearance (where all individuals within a group were culture-negative) for each vaccine antigen was found to be formulation-dependent, with SLA-SE resulting in the shortest time to clearance relative to SLA-AF or SLA-LSQ formulations independent of antigen (Fig. 5C).",
            "startOffset": 31583,
            "title": "Vaccination with rPmpD in the presence or absence of SLA significantly enhances resistance to Ct infection and reduces mean bacterial load"
        },
        {
            "endOffset": 32395,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Although no significant difference in resistance to infection or bacterial load was observed between rPmpD-SLA vaccine formulations (Fig. 6), the time to clearance (Fig. 5) and magnitude of Th1 bias (Fig. 1A) were formulation-dependent.",
            "startOffset": 32159,
            "title": "Vaccination with rPmpD in the presence or absence of SLA significantly enhances resistance to Ct infection and reduces mean bacterial load"
        },
        {
            "endOffset": 16578,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 16577,
                    "startOffset": 16574
                }
            },
            "secId": "s0005",
            "sentence": "Several studies investigating protective immunity and vaccine efficacy have focused on intra-vaginal Cm challenge which typically results in a more prolific ascending infection with lower inoculating doses than Ct, that can rapidly progress to hydrosalpinx and infertility [6].",
            "startOffset": 16301,
            "title": "Introduction"
        },
        {
            "endOffset": 17163,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 17162,
                    "startOffset": 17156
                },
                "b0050": {
                    "endOffset": 17162,
                    "startOffset": 17156
                }
            },
            "secId": "s0005",
            "sentence": "Although a high degree of genomic synteny is apparent, differences within the plasticity zones of Cm and Ct genomes may influence infection outcomes in the murine model [9,10].",
            "startOffset": 16987,
            "title": "Introduction"
        },
        {
            "endOffset": 29881,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "While no significant difference between SLA-AF and SLA-LSQ-induced cervico-vaginal titres were observed, the SLA-SE formulation elicited significantly greater anti-rPmpD IgG titres and IgG2c:IgG1 ratios within the vaginal vault following the final immunization (Fig. 3), consistent with robust induction of Th1-type immunity (Fig. 1A).",
            "startOffset": 29546,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 18854,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 18853,
                    "startOffset": 18849
                }
            },
            "secId": "s0005",
            "sentence": "In contrast, Ct PmpD possesses the highest inter-strain sequence conservation (>99.15%) among the nine-member family, implying a conserved role in biphasic development or virulence [24].",
            "startOffset": 18668,
            "title": "Introduction"
        },
        {
            "endOffset": 28946,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "No rPmpD-specific IgG was detected in mice immunized with PBS or SLA alone, while rPmpD administered in the absence of SLA elicited robust systemic IgG1 humoral immune responses, but showed no detectable IgG of the 2c subclass pre- or post-challenge (Fig. 2C and D).",
            "startOffset": 28680,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 21031,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Following over-expression in E. coli BL21(DE3) strain (Novagen), purification and refolding was implemented by stepwise dialysis of 6 M guanidinium hydrochloride from inclusion bodies, ending up in 20 mM Tris, 50 mM NaCl (pH 8).",
            "startOffset": 20803,
            "title": "Preparation of recombinant PmpD and UV-inactivated Ct EB vaccines"
        },
        {
            "endOffset": 17716,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 17715,
                    "startOffset": 17711
                }
            },
            "secId": "s0005",
            "sentence": "Such observations have cautionary implications for the investigation of chlamydial infections in mice, as it has recently been suggested that innate immunity is sufficient to resolve Ct but not Cm infection [14].",
            "startOffset": 17504,
            "title": "Introduction"
        },
        {
            "endOffset": 27296,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "To evaluate the immunogenicity of rPmpD adjuvanted with different formulations of SLA, C57BL/6 mice were immunized, and splenic rPmpD-specific cellular immune responses elicited by each vaccine formulation were determined using ELISpot both pre- and post-Ct challenge (Fig. 1A\u2013F).",
            "startOffset": 27016,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 36656,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 36655,
                    "startOffset": 36645
                },
                "b0205": {
                    "endOffset": 36655,
                    "startOffset": 36645
                },
                "b0210": {
                    "endOffset": 36655,
                    "startOffset": 36645
                }
            },
            "secId": "s0080",
            "sentence": "Furthermore, the high degree of pan-strain conservation of Ct PmpD and immunodominance in patient cohorts highlights the potential for eliciting broad protection against a diverse array of circulating strains [24,41,42].",
            "startOffset": 36436,
            "title": "Discussion"
        },
        {
            "endOffset": 26028,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "After incubation at 37 \u00b0C with 5% CO2 for 20 h, plates were washed and incubated with respective biotinylated detection antibodies according to manufacturer\u2019s protocol (Mabtech).",
            "startOffset": 25850,
            "title": "Antigen-specific cellular responses"
        },
        {
            "endOffset": 21131,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "This yielded soluble protein that was purified by metal affinity and size exclusion chromatography.",
            "startOffset": 21032,
            "title": "Preparation of recombinant PmpD and UV-inactivated Ct EB vaccines"
        },
        {
            "endOffset": 30872,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Cervico-vaginal swabs were obtained from all vaccine groups on days 1, 3, 7, 14 and 22 following intra-vaginal challenge with Ct serovar D (Fig. 5).",
            "startOffset": 30724,
            "title": "Vaccination with rPmpD in the presence or absence of SLA significantly enhances resistance to Ct infection and reduces mean bacterial load"
        },
        {
            "endOffset": 26717,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 26657,
                    "startOffset": 26650
                },
                "b0110": {
                    "endOffset": 26657,
                    "startOffset": 26650
                }
            },
            "secId": "s0055",
            "sentence": "Sample size calculations were performed in G\u2217Power version 3.1 using both a priori analysis based on previous studies [17,22] and post hoc pilot experiments performed in our laboratory.",
            "startOffset": 26532,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 19179,
            "parents": [],
            "secId": "s0005",
            "sentence": "Here, we provide the first preclinical investigation of a candidate chlamydial vaccine, evaluating three different formulations of a rationally designed TLR4 agonistic second-generation lipid adjuvant (SLA) in combination with Ct rPmpD.",
            "startOffset": 18943,
            "title": "Introduction"
        },
        {
            "endOffset": 30383,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Anti-rPmpD serum from all vaccine groups reacted strongly with rPmpD in both assays, and cross-reacted with UVEBs in ELISAs, showing recognition of epitopes on Ct EBs.",
            "startOffset": 30216,
            "title": "Reactivity of anti-rPmpD and anti-UVEB serum in Western Blot and ELISA"
        },
        {
            "endOffset": 16080,
            "parents": [],
            "secId": "s0005",
            "sentence": "Due to the paucity of robust clinical data, protective immunological parameters have largely been derived from preclinical murine models.",
            "startOffset": 15943,
            "title": "Introduction"
        },
        {
            "endOffset": 24753,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Blocking buffer (1\u00d7 PBS, 0.05% Tween-20, 0.1% BSA) was added (200 \u03bcl/well) and plates incubated for 2hr at room temperature prior to addition of serial dilutions of serum (100 \u03bcl/well) or cervico-vaginal lavage.",
            "startOffset": 24542,
            "title": "Measurement of serum and cervico-vaginal antigen-specific antibody"
        },
        {
            "endOffset": 28428,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Interestingly, only the SLA-SE-induced rPmpD-specific IFN\u03b3 response was significantly boosted following Ct infection (Fig. 1B).",
            "startOffset": 28301,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 23964,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "To prevent protein degradation, 25\u00d7 Protease Inhibitor Cocktail (Sigma\u2013Aldrich) was added.",
            "startOffset": 23874,
            "title": "Cervico-vaginal washes"
        },
        {
            "endOffset": 23399,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0035": {
                    "endOffset": 23398,
                    "startOffset": 23392
                },
                "b0085": {
                    "endOffset": 23398,
                    "startOffset": 23392
                }
            },
            "secId": "s0035",
            "sentence": "Three weeks after the final vaccination, mice were challenged intra-vaginally with 107 IFU of Ct serovar D/UW3/Cx EBs as previously described [7,17].",
            "startOffset": 23250,
            "title": "Vaginal Ct challenge and determination of chlamydial load"
        },
        {
            "endOffset": 26357,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Differences between two independent means were determined with a two-tailed t-test using GraphPad Prism 6.",
            "startOffset": 26251,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 19982,
            "parents": [],
            "secId": "s0005",
            "sentence": "While all SLA formulations elicited significantly enhanced magnitudes of rPmpD-specific Th1-biased immune responses that correlated with resistance to infection and reduced bacterial burden, protection was also observed following immunization with rPmpD alone in the absence of SLA-induced Th1-bias, which coincided with robust anti-rPmpD serum and cervico-vaginal IgG titres.",
            "startOffset": 19606,
            "title": "Introduction"
        },
        {
            "endOffset": 30215,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "To determine reactivity against both native and non conformational-dependent epitopes, ELISA and western blotting were implemented using heat-inactivated serum from rPmpD- and UVEB-immunized mice two weeks following the final boost, prior to challenge (Fig. 4).",
            "startOffset": 29954,
            "title": "Reactivity of anti-rPmpD and anti-UVEB serum in Western Blot and ELISA"
        },
        {
            "endOffset": 21457,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Ct E/Bour elementary bodies were inactivated by UV irradiation (UVEB) at a distance of 15 cm from a UV-lamp for 60 min.",
            "startOffset": 21338,
            "title": "Preparation of recombinant PmpD and UV-inactivated Ct EB vaccines"
        },
        {
            "endOffset": 21865,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Ultra-pure water was added, and the mixture sonicated in a 60 \u00b0C water bath until translucent.",
            "startOffset": 21771,
            "title": "Second-generation lipid adjuvant formulations"
        },
        {
            "endOffset": 24931,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "After incubation for 2 h at 37 \u00b0C, plates were washed and then incubated with HRP-conjugated goat anti-mouse IgG, IgG1 or IgG2c antibodies (AbD Serotec) at 37 \u00b0C for 30 minutes.",
            "startOffset": 24754,
            "title": "Measurement of serum and cervico-vaginal antigen-specific antibody"
        },
        {
            "endOffset": 33818,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 33671,
                    "startOffset": 33667
                },
                "b0175": {
                    "endOffset": 33817,
                    "startOffset": 33813
                }
            },
            "secId": "s0080",
            "sentence": "Robust pathogen-specific Th1-type immunity is widely regarded as a robust parameter for screening preclinical chlamydial vaccines [34], and Stary et al. have recently detailed cell-mediated effector mechanisms underlying vaccine-induced mucosal immunity against Ct infections [35].",
            "startOffset": 33537,
            "title": "Discussion"
        },
        {
            "endOffset": 25053,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "After the final wash step, 50 \u03bcl/well of 3\u2032,5,5\u2032-tetramethylbenzidine (TMB) substrate solution (Sigma-Aldrich) was added.",
            "startOffset": 24932,
            "title": "Measurement of serum and cervico-vaginal antigen-specific antibody"
        },
        {
            "endOffset": 33350,
            "parents": [],
            "secId": "s0080",
            "sentence": "Importantly, we also highlight the protective efficacy of rPmpD against urogenital Ct infection in the absence of adjuvant.",
            "startOffset": 33227,
            "title": "Discussion"
        },
        {
            "endOffset": 26228,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Spot forming units (SFU) were enumerated by eye.",
            "startOffset": 26180,
            "title": "Antigen-specific cellular responses"
        },
        {
            "endOffset": 16795,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 16794,
                    "startOffset": 16791
                }
            },
            "secId": "s0005",
            "sentence": "Thus, the Cm model may be widely applicable for the study of therapeutic vaccines against post-infection sequelae, although intra-vaginal infection with certain Ct serovars can also result in ascending infection [7].",
            "startOffset": 16579,
            "title": "Introduction"
        },
        {
            "endOffset": 35213,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 35212,
                    "startOffset": 35208
                }
            },
            "secId": "s0080",
            "sentence": "Indeed, the only convincing evidence describing a protective role for anti-Ct antibodies in vivo focuses on the antigenically variable MOMP antigen, where passive transfer of serum from immunized mice conferred early protection against infection, suggesting systemic neutralizing antibody is sufficient to mediate lower genital tract protection [37].",
            "startOffset": 34863,
            "title": "Discussion"
        },
        {
            "endOffset": 30583,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Anti-UVEB serum did not cross-react with rPmpD in ELISA or western blot, but reacted with UVEBs in both assays, showing immunodominant recognition of Ct major outer membrane protein (MOMP) (Fig. 4B).",
            "startOffset": 30384,
            "title": "Reactivity of anti-rPmpD and anti-UVEB serum in Western Blot and ELISA"
        },
        {
            "endOffset": 21600,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Second-generation lipid adjuvant (SLA) was synthesised by Corden Pharma (Liestal, Switzerland).",
            "startOffset": 21505,
            "title": "Second-generation lipid adjuvant formulations"
        },
        {
            "endOffset": 17325,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 17324,
                    "startOffset": 17320
                }
            },
            "secId": "s0005",
            "sentence": "Cm possesses three functional paralogous copies of the cytotoxin gene that is truncated and likely non-functional in the majority of urogenital Ct serovars [11].",
            "startOffset": 17164,
            "title": "Introduction"
        },
        {
            "endOffset": 35940,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 35939,
                    "startOffset": 35935
                }
            },
            "secId": "s0080",
            "sentence": "For instance, the Leishmania major hydrophilic acylated surface protein B (HASPB) elicited long-term protection and antigen-specific CD8+ T cells in the absence of exogenous adjuvant or delivery vehicle, where natural antibody binding and complement act as endogenous adjuvants that bridge innate and adaptive immunity [38].",
            "startOffset": 35616,
            "title": "Discussion"
        },
        {
            "endOffset": 25284,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Colour development was stopped after 5 min with 1 M H2SO4 (KPL, USA) and plates were read immediately at 450 nm (OD450) with a VersaMax microplate reader in conjunction with the SoftMax Pro v.5.3 software (Molecular Devices, USA).",
            "startOffset": 25054,
            "title": "Measurement of serum and cervico-vaginal antigen-specific antibody"
        },
        {
            "endOffset": 28679,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The reciprocal titres at 50% maximal binding of anti-rPmpD IgG1 and IgG2c were measured.",
            "startOffset": 28591,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 29427,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "To assess mucosal humoral responses, cervico-vaginal washes were obtained two weeks following the penultimate and final immunizations.",
            "startOffset": 29293,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 36064,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 36063,
                    "startOffset": 36056
                },
                "b0200": {
                    "endOffset": 36063,
                    "startOffset": 36056
                }
            },
            "secId": "s0080",
            "sentence": "Similarly, the leishmanial vaccine candidate antigen LeIF was shown to possess inherent IL-12 stimulating capacity [39,40].",
            "startOffset": 35941,
            "title": "Discussion"
        },
        {
            "endOffset": 36435,
            "parents": [],
            "secId": "s0080",
            "sentence": "Based on our results and the efficacy of precursor molecule GLA in clinical trials, we propose that SLA may be incorporated as a novel adjuvant in future preclinical chlamydial vaccines with significant translational potential.",
            "startOffset": 36208,
            "title": "Discussion"
        },
        {
            "endOffset": 25601,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Enzyme-linked immunospot (ELISpot) assays were performed immediately following splenic harvest.",
            "startOffset": 25506,
            "title": "Antigen-specific cellular responses"
        },
        {
            "endOffset": 23249,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "All animals received a subcutaneous injection of 2.5 mg of medroxyprogesterone acetate (Depo-Provera, Pfizer) one week prior to challenge.",
            "startOffset": 23111,
            "title": "Vaginal Ct challenge and determination of chlamydial load"
        },
        {
            "endOffset": 28590,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "To assess vaccine-induced humoral immunity, rPmpD-specific serum IgG responses were measured two weeks following the penultimate and final boosts (Fig. 2A and C).",
            "startOffset": 28428,
            "title": "SLA in combination with rPmpD induces a robust Th1-type immune response and significantly enhances systemic and cervico-vaginal rPmpD-specific IgG titres"
        },
        {
            "endOffset": 25505,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Animals were euthanized and spleens collected and homogenized into single cell suspensions.",
            "startOffset": 25414,
            "title": "Antigen-specific cellular responses"
        },
        {
            "endOffset": 37134,
            "parents": [],
            "secId": "s0085",
            "sentence": "This research was also funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200800045C and Grant No, U01AI078054 to RC.",
            "startOffset": 36861,
            "title": "Financial support"
        },
        {
            "endOffset": 24330,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "96-well Assay plates (Costar) were coated with 50 \u03bcl rPmpD (1 \u03bcg/ml) at 4 \u00b0C overnight in coating buffer (0.1 M Na2CO3, 0.1 M NaHCO3, pH 9.6).",
            "startOffset": 24188,
            "title": "Measurement of serum and cervico-vaginal antigen-specific antibody"
        },
        {
            "endOffset": 37665,
            "parents": [],
            "secId": "s0090",
            "sentence": "SGR and DC are inventors on issued patents for GLA based formulations and on SLA.",
            "startOffset": 37584,
            "title": "Potential conflicts of interest"
        },
        {
            "endOffset": 18667,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 18666,
                    "startOffset": 18662
                }
            },
            "secId": "s0005",
            "sentence": "However, Pmps E and F are highly polymorphic within genital Ct strains, and PmpG possesses regulatory sequences indicative of phase variation, suggesting a role for Pmps in immune evasion [23].",
            "startOffset": 18474,
            "title": "Introduction"
        },
        {
            "endOffset": 26179,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "This was followed by incubation with streptavidin-alkaline phosphatase (1 h, RT) and addition of BCIP/NBT-plus substrate until distinct spots emerged.",
            "startOffset": 26029,
            "title": "Antigen-specific cellular responses"
        },
        {
            "endOffset": 23696,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Cervico-vaginal washes were obtained on days 34 and 55 post initial immunization.",
            "startOffset": 23615,
            "title": "Cervico-vaginal washes"
        },
        {
            "endOffset": 25376,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Reciprocal serum dilutions corresponding to 50% maximal binding were used to obtain titres.",
            "startOffset": 25285,
            "title": "Measurement of serum and cervico-vaginal antigen-specific antibody"
        },
        {
            "endOffset": 18177,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 18176,
                    "startOffset": 18169
                },
                "b0095": {
                    "endOffset": 18176,
                    "startOffset": 18169
                },
                "b0100": {
                    "endOffset": 18176,
                    "startOffset": 18169
                }
            },
            "secId": "s0005",
            "sentence": "Subunit vaccines have displaced the use of whole-cell organisms following the incidence of inflammatory reactions in non-human primates post challenge, although this was found not to be the case in humans [18\u201320].",
            "startOffset": 17964,
            "title": "Introduction"
        },
        {
            "endOffset": 23051,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Additional groups of mice received rPmpD, SLA-AF, SLA-SE, SLA-LSQ or PBS alone as controls.",
            "startOffset": 22960,
            "title": "Mouse immunizations"
        },
        {
            "endOffset": 20802,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 20715,
                    "startOffset": 20711
                }
            },
            "secId": "s0020",
            "sentence": "A DNA construct encoding the \u223c65 kDa (aa68-aa698) passenger domain fragment previously identified by mass spectrometry following in vitro infection [30] was inserted into the pET 28(b) vector (Novagen) with a C-terminal hexa-histidine tag.",
            "startOffset": 20563,
            "title": "Preparation of recombinant PmpD and UV-inactivated Ct EB vaccines"
        }
    ],
    "docId": "S0264410X16305618",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "wayne.paes@ndm.ox.ac.uk",
                "first": "Wayne",
                "initial": "W.",
                "last": "Paes"
            },
            {
                "email": null,
                "first": "Naj",
                "initial": "N.",
                "last": "Brown"
            },
            {
                "email": null,
                "first": "Andrzej M.",
                "initial": "A.M.",
                "last": "Brzozowski"
            },
            {
                "email": null,
                "first": "Rhea",
                "initial": "R.",
                "last": "Coler"
            },
            {
                "email": null,
                "first": "Steve",
                "initial": "S.",
                "last": "Reed"
            },
            {
                "email": null,
                "first": "Darrick",
                "initial": "D.",
                "last": "Carter"
            },
            {
                "email": null,
                "first": "Martin",
                "initial": "M.",
                "last": "Bland"
            },
            {
                "email": null,
                "first": "Paul M.",
                "initial": "P.M.",
                "last": "Kaye"
            },
            {
                "email": null,
                "first": "Charles J.N.",
                "initial": "C.J.N.",
                "last": "Lacey"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.06.081",
        "firstpage": "4123",
        "issn": "0264410X",
        "keywords": [
            "Chlamydia trachomatis",
            "Pmps",
            "TLR4 adjuvant",
            "Vaccine"
        ],
        "lastpage": "4131",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice"
    }
}